Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Joshua R. Sawyer
Comparative Effectiveness of Darunavir 1,200 Mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients
AIDS Research and Treatment
Immunology
Public Health
Allergy
Environmental
Dermatology
Infectious Diseases
Occupational Health
Related publications
Boosted Tipranavir Versus Darunavir in Treatment-Experienced Patients
Drugs in R and D
Pharmacology
Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Daily Dosing for Bedaquiline in Patients With Tuberculosis
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged≥3 to <12 Years
CPT: Pharmacometrics and Systems Pharmacology
Modeling
Simulation
Cardiovascular Medicine
Pharmacology
Cardiology
Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients
Current HIV Research
Virology
Infectious Diseases
Comparative Effectiveness of Revascularization Strategies
New England Journal of Medicine
Medicine
Comparative Effectiveness of Screening Strategies for Colorectal Cancer
Cancer
Cancer Research
Oncology
Appropriate Clinical Use of Darunavir 800 Mg
Southern African Journal of HIV Medicine
Infectious Diseases
Pin61 - Cost-Effectiveness of Once-Daily Darunavir Containing Single-Tablet Regimen (D/C/F/Taf) Compared With Other Multi-Tablet Regimens Containing Boosted Protease Inhibitors (Bpis)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
